講演者

Hiroshi Abe, PhD

Professor, Department of Chemistry, Graduate School

Nagoya University

Anubrato Aich

Senior Project Manager

AmbioPharm

Shiro Akinaga, PhD

President and CEO

NANO MRNA, Co., Ltd.

Mark Anastasas

Group Lead Chemistry-QC

PYC Therapeutics

Arne Berthelmann

Senior Director Oligonucleotide R&D

Bachem AG

Dr. Kerry Blanchard, MD, PhD

CEO, Chairman and Founder

Perpetual Medicines

Dr. Molly Blevins, PhD

Principal Scientist

Genentech

Dr. Marvin Caruthers, PhD

Distinguished Professor, Biochemistry

University of Colorado

Pad Chivukula, PhD

Chief Scientific Officer and COO

Arcturus Therapeutics

David Craik, PhD

Professor of Biomolecular Structure

University of Queensland

Mr. Keith Cronce

Chief Operating Officer

Fluid Air, A Division of Spraying Systems

Alaric Desmarchelier, PhD

Business Development Manager - Peptides

Almac Group

Alun Garner

Business Development Manager, Nucleic Acid Solutions Division

Agilent Technologies

Robert Gronke, PhD

Senior Principal Scientist

Biogen, Inc

Robert Hagopian

Global Director, Biotech Partnerships

PolyPeptide Group

Yuta Hiroyama

Senior Scientist, Process Chemistry Group, R&D Department

PeptiStar

Sunhee Hwang, PhD

Scientist 4

Genentech

Masafumi Iwamoto, PhD

Associate Director of Technology and Innovation

Nitto Denko Avecia

Marc Jacob, PhD

Head of Strategic Development, Chromatography Products

YMC America

Naresh Jain, PhD

CEO

NJ Bio

Dr. Lotte Bjerre Knudsen, PhD

Chief Scientific Advisor & Head of GLP-1 CoE

Novo Nordisk A/S

Dr. Haruaki Kurasaki, PhD

Director, Medicinal Chemistry

PeptiDream

Jung Hwan Lee, PhD

CEO

Interoligo Corp.

David Lin, PhD

President and Principal Consultant

TS Pharma Experts LLC

Dr. Pablo Lores Lareo, PhD

CMC Director

Sylentis

Dr. Long Ma, PhD

CEO and Chief Scientist

Orilife Biotech

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Innovation and Distinguished Research Scientist

Alnylam Pharmaceuticals

Jody Mason, PhD

Professor of Biochemistry

University of Bath

Dr. Scott May, PhD

VP of Chemistry, Synthetic Molecule Design & Development

Eli Lilly and Company

Bruce Morimoto, PhD

Independent Consultant

TIDES Advisor

David O'Connell, PhD

Professor, School of Biomolecular & Biomedical Science

University College Dublin

Chris Oswald

Founder, Owner, and Principal Consultant

Coswald Consulting LLC

Dr. Lei Qian, MD, PhD

Chief R&D Officer, General Biomedicine

Innoventbio

El Djouhar Rekaï, PhD

Head of Peptide Process Development & Manufacturing

PolyPeptide Group

Fabien Rousset, PhD

Global Director of Innovation

Polypeptide Group

Thomas Rupp

Owner & Principal

Thomas Rupp Consulting

Yogesh Sanghvi, PhD

President

Rasayan Inc.

Alfica Sehgal, PhD

Chief Scientific Officer

Judo Bio

Chikdu Shivalila, PhD

Senior Scientist, Biology

Wave Life Sciences

Ved Srivastava, PhD

CTO

Perpetual Medicines

Dr. Tomoya Takenaka, PhD

Principal Scientist, Drug Product and Device Development

Takeda Pharmaceutical Company

Hideki Tomioka, PhD

Director of the Board and CSO

FunPep Co., Ltd.

Dr. Kumiko Ui-Tei, PhD

CTO, ANRis Therapeutics and Director/Professor NucleoTIDE & PepTIDE Drug Discovery Center

Institute of Science Tokyo

Dr. Takeshi Wada, PhD

Professor of Organic Chemistry

Tokyo University of Science

Dr. Manabu Wadamoto, PhD

Chief Scientist

Chugai Pharmaceutical Co., Ltd.

Dr. Hiroshi Yamada, PhD

Head of Drug Delivery Research and Development

Nitto Denko Corporation

Husam Younis, PhD

Senior Vice President, Development Science

Avidity Biosciences

Dr. Stefano Zanotti, PhD

VP, Head of Neuromuscular Research

Dyne Therapeutics

Dr. Xin Zhang, PhD

Principal Scientist

Denali Therapeutics

Yingnan Zhang, PhD

Senior Principal Scientific Manager

Genentech

Dr. Hien Zhao, PhD

Vice President, Neuroscience Research

Ionis Pharmaceuticals